The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-01

Study Completion Date

2030-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An observational, ambispective cohort to learn about the disease progression of axial spondyloarthritis (axSpA) according to the changes from baseline in measures of disease activity, function, and imaging.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Description of Spondylarthritis and Validation of ASAS Criteria in West Indian Patients Seen in Consultation of Rheumatology.

NCT03564743

Spondyloarthritis

COMPLETED

Bidirectional Cohort Study of Nanfang Spondyloarthritis

NCT06988813

Spondyloarthritis (SpA) Ankylosing Spondylitis (AS)

RECRUITING

Biomarkers in Early-stage Spondyloarthritis

NCT04095169

Ankylosing Spondylitis Spondyloarthritis

COMPLETED

Clinical Trial of TCM Collaborative Care Model in Axial Spondyloarthritis

NCT03420404

Axial Spondyloarthritis

ACTIVE_NOT_RECRUITING NA

Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis

NCT03190603

Spondylarthropathies Magnetic Resonance Imaging

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an observational cohort study of Chinese patients (≥18 years of age) diagnosed with axSpA. Patients are followed at 4-6 month intervals. Data will be collected at baseline and at every follow-up time points. Primary outcomes are the structural damage measured with imaging(Conventional radiography, low-dose CT and MRI) and the disease activity measured with the Ankylosing Spondylitis Disease Activity Scale (ASDAS) and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Secondary outcomes are inflammatory markers, Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Axial Spondyloarthritis Ankylosing Spondylitis (AS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 years or older and diagnosed with the Assessment of Spondyloarthritis International Society axial spondyloarthritis criteria.

Exclusion Criteria

* Patients with serious disease in cardiovascular, kidney and blood and endocrine system; history of schizophrenia or epilepsy; pregnant or in lactation period.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No